Regulatory Automation Platomics specializes in automating regulatory processes for in vitro diagnostic (IVD) manufacturers and laboratories, presenting a clear upsell path to clients seeking faster IVDR compliance and reduced regulatory overhead.

Strategic Partnerships Recent and ongoing collaborations with Pillar Biosciences, Agilent Technologies, Twist Bioscience, Biocrates Life Sciences, Sequentia Biotech, and others suggest multiple co-sell and integration opportunities to expand platform reach and joint value in regulatory data management and analytics.

Platform as Value The PlatoX platform differentiates by digitalizing regulatory work via intelligent data rather than documents, offering a compelling pitch to labs and manufacturers aiming to cut time, resources, and costs in IVDR workflows.

Growth Through NGS With strong focus on next-generation sequencing and collaboration with Agilent and Pillar Biosciences for IVDR-compliant NGS workflows, target opportunities exist in labs expanding NGS panels and metabolomics integration via regulatory automation.

Sizable Funding Signals Funding and revenue indicators (revenue range of 1–10M and total funding around 16M) imply a venture-backed, growth-ready sales motion; align outreach to mid-market and strategic enterprise buyers looking to scale regulatory operations.